Pfizer Inc

PFE

New York Stock Exchange. Currency in USD

43.76 -0.40 ( -0.91% )

Real time prices: September 30

Market Cap.
245.60B
Beta (5Y monthly)
0.65
Price/Earnings
7.26
EPS (TTM)
6.08
Forward Dividend
1.60 (3.63%)
Ex-Dividend Date
Nov 04, 2022
Volume
22.96M
1y Target Est.
56.81
Day's Range
43.73
-
44.60
52 Week's Range
40.94
-
61.71

Historical Summary

Performance
EPS growth
Share Buybacks

About Pfizer Inc

Sector
Healthcare
Industry
Drug Manufacturers-General
Website
https://www.pfizer.com
Exchange
New York Stock Exchange (XNYS)
Shares Outstanding
5.61B
Employees
79000
Address
235 East 42nd Street, New York, NY, United States, 10017
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Latest news

Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades
Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades

Dividend stocks could be your best friend right now.
By The Motley Fool - 17 hours ago

3 Growth Stocks Poised to Skyrocket
3 Growth Stocks Poised to Skyrocket

Two of these three stocks are already soaring this year.
By The Motley Fool - 1 day ago

Here's Why the Post-Pandemic World May Be Even Better for This Vaccine Maker
Here's Why the Post-Pandemic World May Be Even Better for This Vaccine Maker

Moderna's billion-dollar revenue may be just getting started.
By The Motley Fool - 1 day ago

Biohaven Pharma's (BHVN) ALS Study Fail to Meet Both Endpoints
Biohaven Pharma's (BHVN) ALS Study Fail to Meet Both Endpoints

Biohaven Pharmaceuticals (BHVN) suffers a setback as verdiperstat fails to meet the primary and secondary...
By Zacks Investment Research - 2 days ago

1 in 5 of Americans don't know about new omicron-targeting COVID boosters, survey finds
1 in 5 of Americans don't know about new omicron-targeting COVID boosters, survey finds

A Kaiser Family Foundation survey found that about half of Americans have heard little or...
By MarketWatch - 2 days ago

Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks

The traditional ways to plan for your retirement may mean income can no longer cover...
By Zacks Investment Research - 2 days ago

EMA Accepts Moderna's (MRNA) Filing for Omicron BA.4, BA.5 Booster
EMA Accepts Moderna's (MRNA) Filing for Omicron BA.4, BA.5 Booster

The EMA accepts Moderna's (MRNA) regulatory filing seeking authorization for bivalent COVID-19 booster vaccine, mRNA-1273.222,...
By Zacks Investment Research - 3 days ago

Pfizer (PFE), BNTX Seek EU Nod for Omicron Booster in Kids
Pfizer (PFE), BNTX Seek EU Nod for Omicron Booster in Kids

Pfizer (PFE) and BioNTech seek to expand the EU label of their Omicron BA.4/BA.5-adapting bivalent...
By Zacks Investment Research - 3 days ago